Cyclerion Therapeutics (CYCN) EBT (2018 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly EBT of -$1.0 million for Q3 2025, up 10.82% year-over-year from -$907814.4 in Q3 2024, and up 39.83% quarter-over-quarter from -$1.7 million in Q2 2025.
Cyclerion Therapeutics (CYCN) EBT (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' EBT history runs 8 years deep, the most recent figure standing at -$1.0 million for Q3 2025.
- In Q3 2025, EBT rose 10.82% year-over-year to -$1.0 million; the TTM figure through Sep 2025 stood at -$3.6 million (up 38.68% YoY), while the FY2024 annual figure was -$86.8 million, up 9.02% from the prior year.
- EBT for Q3 2025 stood at -$1.0 million, up from -$1.7 million in the prior quarter.
- The five-year high for EBT was $502000.0 in Q4 2024, with the low at -$18.5 million in Q2 2021.
- The 5-year median for EBT is -$3.4 million (2023), against an average of -$6.2 million.
- The sharpest annual moves came in 2023 and 2024: EBT dropped 29.61% in 2023, then surged 127.97% in 2024.
- Cyclerion Therapeutics' EBT stood at -$15.7 million in 2021, then soared by 71.67% to -$4.5 million in 2022, then soared by 59.71% to -$1.8 million in 2023, then soared by 127.97% to $502000.0 in 2024, then sank by 300.4% to -$1.0 million in 2025.
- Business Quant data shows CYCN's EBT at -$1.0 million in Q3 2025, -$1.7 million in Q2 2025, and -$1.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 81.49 Mn |
| 10 | Cyclerion Therapeutics | 12.35 Mn | 9.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -1.67 Mn |
| Mar 31, 2025 | -1.46 Mn |
| Dec 31, 2024 | 502,000.00 |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -1.38 Mn |
| Mar 31, 2024 | -1.62 Mn |
| Dec 31, 2023 | -1.80 Mn |
| Sep 30, 2023 | -6.12 Mn |
| Jun 30, 2023 | -1.97 Mn |
| Mar 31, 2023 | -3.38 Mn |
| Dec 31, 2022 | -4.46 Mn |
| Sep 30, 2022 | -4.72 Mn |
| Jun 30, 2022 | -13.63 Mn |
| Mar 31, 2022 | -13.18 Mn |
| Dec 31, 2021 | -15.73 Mn |
| Sep 30, 2021 | -12.16 Mn |
| Jun 30, 2021 | -18.49 Mn |
| Mar 31, 2021 | -14.80 Mn |
| Dec 31, 2020 | -20.56 Mn |